← Eichor
Study identifier: NCT07275554 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure

Condition: HBV Related Acute-on-chronic Liver Failure · HBV-related Liver Cirrhosis · HBV (Hepatitis B Virus)  ·  Sponsor: Qilu Hospital of Shandong University

PhaseN/A
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study aims to investigate the methylomic features of patients with hepatitis B-related acute-on-chronic liver failure and establish and validate a prognostic risk prediction classification model. The findings are of significant importance for guiding clinical practice and improving patient prognosis. Additionally, a methylomics-based classifier model for liver failure will be developed for disease prognosis analysis and clinical assessment, with the potential to enhance the diagnostic efficiency of liver failure.

This description comes directly from the study's public registry record.

Talk to the study team

Yu-Chen Fan  ·  0086+053182169593  ·  fanyuchen@sdu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Qilu Hospital of Shandong UniversityJinan, Shandong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07275554